Matthew Taylor

Assistant Professor

    • 1921 Citations
    • 7 h-Index
    20102018

    Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 2 Similar Profiles
    Thyroid Neoplasms Medicine & Life Sciences
    Neoplasms Medicine & Life Sciences
    Safety Medicine & Life Sciences
    docetaxel Medicine & Life Sciences
    Local Neoplasm Recurrences Medicine & Life Sciences
    Disease Progression Medicine & Life Sciences
    Placebos Medicine & Life Sciences
    Melanoma Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2010 2018

    • 1921 Citations
    • 7 h-Index
    • 16 Article
    • 1 Comment/debate
    7 Citations

    Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

    Patel, M. R., Ellerton, J., Infante, J. R., Agrawal, M., Gordon, M., Aljumaily, R., Britten, C. D., Dirix, L., Lee, K. W., Taylor, M., Schöffski, P., Wang, D., Ravaud, A., Gelb, A. B., Xiong, J., Rosen, G., Gulley, J. L. & Apolo, A. B. Jan 1 2018 In : The Lancet Oncology. 19, 1, p. 51-64 14 p.

    Research output: Contribution to journalArticle

    Platinum
    Carcinoma
    Neoplasms
    Safety
    avelumab
    1 Citations

    Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study

    Gambacorti-Passerini, C., Orlov, S., Zhang, L., Braiteh, F., Huang, H., Esaki, T., Horibe, K., Ahn, J. S., Beck, J. T., Edenfield, W. J., Shi, Y., Taylor, M., Tamura, K., Van Tine, B. A., Wu, S. J., Paolini, J., Selaru, P. & Kim, T. M. Jan 1 2018 (Accepted/In press) In : American Journal of Hematology.

    Research output: Contribution to journalArticle

    Non-Small Cell Lung Carcinoma
    Neoplasms
    Lymphoma
    Confidence Intervals
    Safety

    Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

    Kelly, K., Infante, J. R., Taylor, M. H., Patel, M. R., Wong, D. J., Iannotti, N., Mehnert, J. M., Loos, A. H., Koch, H., Speit, I. & Gulley, J. L. Jan 1 2018 (Accepted/In press) In : Cancer.

    Research output: Contribution to journalArticle

    Clinical Trials
    Safety
    Neoplasms
    avelumab
    CD274 Antigen

    Signature program: A platform of basket trials

    Slosberg, E. D., Kang, B. P., Peguero, J., Taylor, M., Bauer, T. M., Berry, D. A., Braiteh, F., Spira, A., Meric-Bernstam, F., Stein, S., Piha-Paul, S. A. & Salvado, A. Apr 20 2018 In : Oncotarget. 9, 30, p. 21383-21395 13 p.

    Research output: Contribution to journalArticle

    Neoplasms
    Mutation
    Hematologic Neoplasms
    Clinical Studies
    Therapeutics

    Academic cancer center phase i program development

    Frankel, A. E., Flaherty, K. T., Weiner, G. J., Chen, R., Azad, N. S., Pishvaian, M. J., Thompson, J. A., Taylor, M. H., Mahadevan, D., Lockhart, A. C., Vaishampayan, U. N., Berlin, J. D., Smith, D. C., Sarantopoulos, J., Riese, M., Saleh, M. N., Ahn, C. & Frenkel, E. P. Apr 1 2017 In : Oncologist. 22, 4, p. 369-374 6 p.

    Research output: Contribution to journalComment/debate

    Program Development
    Neoplasms
    Research
    Research Personnel
    Clinical Trials